FTC warns Novo that current Metsera offer structure may violate US merger law
5th November 2025 Uncategorised 0In a letter to lawyers for Novo and Metsera, an FTC official wrote that the proposed purchase of Metsera by the Danish pharma “may violate the procedural provisions” of the Hart-Scott-Rodino (HSR) Act.
More: FTC warns Novo that current Metsera offer structure may violate US merger law
Source: fierce
